Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Ginkgo Bioworks Holdings, Inc. (DNA)

2   0.04 (2.04%) 02-07 16:00
Open: 1.94 Pre. Close: 1.96
High: 2.02 Low: 1.9
Volume: 19,641,476 Market Cap: 3,963(M)

Technical analysis

as of: 2023-02-07 4:27:45 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.62     One year: 3.06
Support: Support1: 1.75    Support2: 1.45
Resistance: Resistance1: 2.25    Resistance2: 2.62
Pivot: 1.88
Moving Average: MA(5): 2.04     MA(20): 1.85
MA(100): 2.26     MA(250): 2.82
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 60.1     %D(3): 71
RSI: RSI(14): 55.4
52-week: High: 5.55  Low: 1.45
Average Vol(K): 3-Month: 23,223 (K)  10-Days: 19,996 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ DNA ] has closed below upper band by 29.5%. Bollinger Bands are 14.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.02 - 2.03 2.03 - 2.04
Low: 1.88 - 1.89 1.89 - 1.9
Close: 1.98 - 2 2 - 2.02

Company Description

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Headline News

Wed, 08 Feb 2023
Two for One: Simultaneous Sequencing of Genetic and Epigenetic ... - Genetic Engineering & Biotechnology News

Tue, 07 Feb 2023
Sailor who died in Pearl Harbor attack identified through DNA testing - New York Post

Tue, 07 Feb 2023
Russia Legalizes Massive DNA Collection Without Oversight - Human Rights Watch

Tue, 07 Feb 2023
Adopted Woman Backed Over Why She Wants Fiancé to Take a DNA test - Newsweek

Tue, 07 Feb 2023
Illumina Attracts Challengers for DNA Sequencing Ahead of Earnings - Barron's

Mon, 06 Feb 2023
How relatively new DNA technology helped solve Lexington serial rape case - LEX 18 News - Lexington, KY

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 1,470 (M)
Shares Float 738 (M)
% Held by Insiders 12.8 (%)
% Held by Institutions 94 (%)
Shares Short 125,510 (K)
Shares Short P.Month 114,290 (K)

Stock Financials

EPS -1.68
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.87
Profit Margin (%) 0
Operating Margin (%) -692.9
Return on Assets (ttm) -113.7
Return on Equity (ttm) -231.4
Qtrly Rev. Growth -14.4
Gross Profit (p.s.) 0.12
Sales Per Share 0.35
EBITDA (p.s.) -2.47
Qtrly Earnings Growth 0
Operating Cash Flow -313 (M)
Levered Free Cash Flow 1,140 (M)

Stock Valuations

PE Ratio -1.2
PEG Ratio 0
Price to Book value 2.29
Price to Sales 5.56
Price to Cash Flow -9.4

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.